Sulforaphane downregulated fatty acid synthase and inhibited microtubule-mediated mitophagy leading to apoptosis

Yuting Yan1,2,3, Yan Zhou1,2, Juntao Li1,2

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Cell Death & Disease
|October 8, 2021
PubMed

Insights

Sulforaphane (SFN) triggers apoptosis in non-small cell lung cancer (NSCLC) by disrupting microtubule function and inhibiting mitophagy, leading to cancer cell death.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Sulforaphane (SFN) previously showed potential in inhibiting autophagy and inducing apoptosis in non-small cell lung cancer (NSCLC).
  • The precise subcellular mechanisms underlying SFN's anti-cancer effects remained largely unknown.

Purpose of the Study:

  • To elucidate the subcellular mechanisms by which SFN induces apoptosis in NSCLC cells.
  • To investigate the role of microtubules, fatty acid metabolism, and mitophagy in SFN's mechanism of action.

Main Methods:

  • High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) to analyze protein and metabolite changes.
  • Western blotting and co-immunoprecipitation to assess protein interactions and levels.
  • Transmission electron microscopy (TEM) for ultrastructural analysis of mitochondria.
  • Gene knockdown experiments (FASN, α-tubulin) to determine functional significance.

Main Results:

  • SFN depolymerized microtubules and downregulated fatty acid synthase (FASN), a key factor in cancer malignancy.
  • SFN inhibited fatty acid synthesis by downregulating FASN, ACACA, and ACLY, and decreased intracellular fatty acids and mitochondrial phospholipids.
  • SFN impaired mitophagy by inhibiting mitophagosome-lysosome fusion, leading to accumulation of abnormal mitochondria and inducing apoptosis, an effect linked to microtubule-NIX interactions.

Conclusions:

  • SFN induces apoptosis in NSCLC cells through a novel mechanism involving microtubule destabilization and inhibition of mitophagy.
  • The findings highlight the intricate interplay between microtubule dynamics, fatty acid metabolism, and mitophagy in SFN-mediated cancer cell death.
  • This study provides new subcellular insights into SFN's anti-cancer properties, potentially opening avenues for novel therapeutic strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.1K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.3K